Epigenetic Changes Induced by Reactive Oxygen Species in Hepatocellular Carcinoma: Methylation of the E-cadherin Promoter

Gastroenterology

Volumn 135, Issue 6, 2008, Pages

  Lim, Seung Oe ^a   Gu, Jin Mo ^a   Kim, Min Sook ^a   Kim, Hyun Soo ^a   Park, Young Nyun ^b   Park, Cheol Keun ^c   Cho, Jae Won ^c   Park, Young Min ^d   Jung, Guhung ^a  

^a Seoul National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Bundang Jesaeng Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; HISTONE DEACETYLASE 1; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; DNA METHYLATION; DOWN REGULATION; ENZYME INDUCTION; EPIGENETICS; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; MOLECULAR MECHANICS; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; UPREGULATION;

EID: 57249103576     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.07.027     Document Type: Article

References (33)

1. Ballestar E., Paz M.F., Valle L., et al. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 22 (2003) 6335-6345
2. Cedar H. DNA methylation and gene activity. Cell 53 (1988) 3-4
3. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
4. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21 (2002) 5427-5440
5. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
6. Hussain S.P., Hofseth L.J., and Harris C.C. Radical causes of cancer. Nat Rev Cancer 3 (2003) 276-285
7. Wu W.S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25 (2006) 695-705
8. Radisky D.C., Levy D.D., Littlepage L.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436 (2005) 123-127
9. Mori K., Shibanuma M., and Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 64 (2004) 7464-7472
10. Cat B., Stuhlmann D., Steinbrenner H., et al. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 119 (2006) 2727-2738
11. Peinado H., Ballestar E., Esteller M., et al. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 24 (2004) 306-319
12. Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 12 (2002) 373-379
13. Gupta G.P., and Massague J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
14. Peinado H., Olmeda D., and Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer 7 (2007) 415-428
15. Wells A. Cell moltility in cancer invasion and metastasis (2006), Springer, The Netherlands 189-220
16. Endo K., Ueda T., Ueyama J., et al. Immunoreactive E-cadherin, α-catenin, β-catenin, and γ-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 31 (2000) 558-565
17. Anthony P.P. Hepatocellular carcinoma: an overview. Histopathology 39 (2001) 109-118
18. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
19. Katoh H., Shibata T., Kokubu A., et al. Epigenetic instability and chromosomal instability in hepatocellular carcinoma. Am J Pathol 168 (2006) 1375-1384
20. Kanai Y., Ushijima S., Hui A.M., et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71 (1997) 355-359
21. Matsumura T., Makino R., and Mitamura K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 7 (2001) 594-599
22. Yoshiura K., Kanai Y., Ochiai A., et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A 92 (1995) 7416-7419
23. Edmondson H.A., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7 (1954) 462-503
24. Graff J.R., Herman J.G., Myohanen S., et al. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 272 (1997) 22322-22329
25. Zinn R.L., Pruitt K., Eguchi S., et al. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67 (2007) 194-201
26. Giannelli G., Bergamini C., Fransvea E., et al. Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129 (2005) 1375-1383
27. Rhyu D.Y., Yang Y., Ha H., et al. Role of reactive oxygen species in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16 (2005) 667-675
28. Zhou B.P., Deng J., Xia W., et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6 (2004) 931-940
29. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116 (2003) 1175-1186
30. Gaudet F., Hodgson J.G., Eden A., et al. Induction of tumors in mice by genomic hypomethylation. Science 300 (2003) 489-492
31. Eads C.A., Danenberg K.D., Kawakami K., et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 59 (1999) 2302-2306
32. Kanai Y., Ushijima S., Kondo Y., et al. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 91 (2001) 205-212
33. Park H.J., Yu E., and Shim Y.H. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Cancer Lett 233 (2006) 271-278